Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy—the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study
IntroductionInflammatory bowel diseases (IBDs) are chronic diseases of unknown cause characterised by a progressive and unpredictable disease course. In the last decade, biological treatment has become a cornerstone in the treatment of IBD. However, one-in-three-to-four patients do not respond to fi...
Main Authors: | Jakob Benedict Seidelin, Andreas Munk Petersen, Johan Burisch, Flemming Bendtsen, Mirabella Zhao, Lone Larsen, Christian Hvas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-02-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/2/e035756.full |
Similar Items
-
Systematic review and meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn’s disease
by: Mohamed Attauabi, et al.
Published: (2021-06-01) -
IBD metabonomics predicts phenotype, disease course, and treatment response
by: Jacob T. Bjerrum, et al.
Published: (2021-09-01) -
THE ROLE OF A COLONOSCOPY IN INFLAMMATORY BOWEL DISEASE (IBD)
by: Davorin Dajčman
Published: (2008-09-01) -
Role of Probiotics and Their Metabolites in Inflammatory Bowel Diseases (IBDs)
by: Toumi Ryma, et al.
Published: (2021-02-01) -
Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
by: Jihye Park, et al.
Published: (2021-09-01)